Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
September 30, 2026 255.34M
June 30, 2026 235.60M
March 31, 2026 229.03M
December 31, 2025 256.79M
September 30, 2025 244.98M
June 30, 2025 234.97M
March 31, 2025 237.96M
December 31, 2024 248.46M
September 30, 2024 260.94M
June 30, 2024 269.26M
March 31, 2024 281.15M
December 31, 2023 285.50M
September 30, 2023 287.20M
June 30, 2023 296.30M
March 31, 2023 306.32M
Date Value
December 31, 2022 311.78M
September 30, 2022 320.50M
June 30, 2022 332.36M
March 31, 2022 343.92M
December 31, 2021 343.33M
September 30, 2021 343.79M
June 30, 2021 334.56M
March 31, 2021 328.08M
December 31, 2020 -37.78M
September 30, 2020
June 30, 2020
March 31, 2020
December 31, 2019
September 30, 2019
June 30, 2019 74.19M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Regional Health Properties, Inc. 2.082M
Chemed Corp. 861.42M
The Ensign Group, Inc. 2.559B
National HealthCare Corp. 1.125B
Oncologix Tech, Inc. --

Shareholders Equity (Quarterly) Related Metrics